摘要 |
Urea derivatives represented by the following general formula (I): which have an agonism of V2 receptor, are useful as agents for the treatment or prevention of diabetes insipidus, nocturia, nocturnal enuresis, overactive bladder or the like. In the formula, R<SUP>1 </SUP>represents a hydrogen atom or a C<SUB>1-6 </SUB>alkyl group which may have a substituent, R<SUP>2 </SUP>is a hydrogen atom or a C<SUB>1-6 </SUB>alkyl group, R<SUP>3 </SUP>is a hydrogen atom, a C<SUB>1-6 </SUB>alkyl group or the like, R<SUP>4</SUP>, R<SUP>5 </SUP>and R<SUP>6 </SUP>are independently a hydrogen atom, a halogen atom or the like, R<SUP>7 </SUP>is a hydrogen atom, a heteroaryl group which may have a substituent, a C<SUB>3-8 </SUB>cycloalkyl group, an amino group which may have a substituent or a C<SUB>1-6 </SUB>alkoxy group which may have a substituted group, M<SUP>1 </SUP>is a single bond, a C<SUB>1-4 </SUB>alkylene group or the like, Y is N or CR<SUP>F </SUP>(in the formula, and R<SUP>F </SUP>represents a hydrogen atom, a C<SUB>1-6 </SUB>alkyl group or the like, or pharmaceutically acceptable salts thereof, or prodrugs thereof, or pharmaceutical compositions comprising the same and pharmaceutical uses thereof.
|